Skip to main content
VCbacked
Log inGet Started

Bluejay Therapeutics

San Mateo, United States

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

$182.0M raised
May 2024
Series C
BiotechnologyHealth CarePharmaceutical

Top Investors

Wellington ManagementRA Capital ManagementNovo HoldingsRiverVestFrazier Life Sciences

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bluejay Therapeutics

How much funding has Bluejay Therapeutics raised?
Bluejay Therapeutics has raised $182.0M in total funding. The most recent round was Series C. The last funding was announced in May 2024.
Who are Bluejay Therapeutics's investors?
Bluejay Therapeutics's investors include Wellington Management, RA Capital Management, Novo Holdings, RiverVest, Frazier Life Sciences.
Where is Bluejay Therapeutics headquartered?
Bluejay Therapeutics is headquartered in San Mateo, United States.
What does Bluejay Therapeutics do?
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
What stage is Bluejay Therapeutics at?
Bluejay Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Bluejay Therapeutics — Funding & Investors." VCBacked, May 9, 2024, https://www.vcbacked.co/company/bluejay-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Bluejay Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/bluejay-therapeutics
Wikipedia (cite web)
{{cite web |title=Bluejay Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bluejay-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong